Tandem Diabetes Care, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 169.38 million compared to USD 175.91 million a year ago. Net loss was USD 123.87 million compared to USD 14.72 million a year ago.

Basic loss per share from continuing operations was USD 1.92 compared to USD 0.23 a year ago.